Maravai Lifesciences Reports Second Quarter 2022 Financial Results
Maravai LifeSciences Holdings, Inc. - Class A common stock (MRVI)
Company Research
Source: GlobeNewswire
SAN DIEGO, Aug. 04, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the second quarter ended June 30, 2022, together with other business updates. Highlights include: Quarterly revenue of $242.7 million, an increase of 11% over the prior year;Nucleic Acid Production base business revenue (excluding estimated COVID-19 related CleanCap® revenue) increased 27% over the prior year;Net income of $156.7 million for the second quarter, representing growth of 17% over the prior year;Record EBITDA margins of XX% and adjusted EBITDA margins of 78%;Cooperative Agreement signed with the Department of Defense to partially fund planned manufacturing expansion of Nucleic Acid Production capabilities in San Diego, California;Expansion of leadership team with the addition of Pete Leddy, Executive Vice President and Chief Administra
Show less
Read more
Impact Snapshot
Event Time:
MRVI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRVI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRVI alerts
High impacting Maravai LifeSciences Holdings, Inc. - Class A common stock news events
Weekly update
A roundup of the hottest topics
MRVI
News
- Should You Sell Maravai LifeSciences (MRVI)? [Yahoo! Finance]Yahoo! Finance
- Maravai LifeSciences Announces March 2024 Investor Conference ScheduleGlobeNewswire
- Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Just Released Its Annual Results And Analysts Are Updating Their Estimates [Yahoo! Finance]Yahoo! Finance
- Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI) Q4 2023 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) had its price target raised by analysts at Royal Bank of Canada from $12.00 to $14.00. They now have an "outperform" rating on the stock.MarketBeat
MRVI
Earnings
- 2/22/24 - Beat
MRVI
Sec Filings
- 3/18/24 - Form 4
- 3/18/24 - Form 4
- 3/18/24 - Form 4
- MRVI's page on the SEC website